FNEVY yields 3.51% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, FNEVY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FNEVY + JNJ for your $10,000?
Fraser and Neave, Limited engages in the food and beverage, and publishing and printing businesses in Singapore, Malaysia, Thailand, Vietnam, and internationally. The company operates through Beverages, Dairies, Printing and Publishing, and Others segments. It produces and sells beverages, including 100PLUS isotonic drinks, F&N NUTRISOY soya milk, F&N sparkling drinks, F&N ICE MOUNTAIN drinking and sparkling water, F&N NUTRIWELL Asian drinks, F&N SEASONS Asian drinks and fruit teas, F&N FRUIT TREE FRESH juice drinks, and F&N cordials. The company also provides dairy products comprising sweetened condensed milk, evaporated milk, pasteurized milk and tea, UHT milk, juices, yoghurt, and ice cream primarily under the F&N MAGNOLIA, F&N, FARMHOUSE, and F&N KING'S brand names. In addition, it publishes education, general interest, and business information content under the MARSHALL CAVENDISH brand; provides digital and offset print services; distributes books and magazines; and retails English language books under the TIMES BOOKSTORES brand. The company was founded in 1883 and is headquartered in Singapore. Fraser and Neave, Limited is a subsidiary of TCC Assets Limited.
Full FNEVY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.